# Croda enters supply contract with Pfizer for COVID-19 vaccine excipients

Croda International entered into a five-year agreement with Pfizer to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate, with an initial three-year supply contract for four component excipients.

- Type: Contract
- Announced: 2020-11-11
- Status: announced
- Products: excipients for COVID-19 vaccine
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Croda International](https://endata.com/companies/23250.md)
- [Pfizer](https://endata.com/companies/892.md) (customer)

## Sources

- [drug-dev.com](https://drug-dev.com/croda-enters-contract-with-pfizer-for-innovative-delivery-system-for-covid-19-vaccine/), 2020-11-11: "Croda International Plc, the speciality chemical company that uses smart science to create high-performance ingredients and technologies that improve lives, recently announced it has entered into an agreement with Pfizer Inc. to supply novel excipients used in the manufacture of a COVID-19 vaccine c"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.